Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Apr 26, 2020
Date Accepted: Jul 7, 2020

The final, peer-reviewed published version of this preprint can be found here:

Accelerating Innovation in Health Care: Insights From a Qualitative Inquiry Into United Kingdom and United States Innovation Centers

Cresswell K, Williams R, Carlisle N, Skeikh A

Accelerating Innovation in Health Care: Insights From a Qualitative Inquiry Into United Kingdom and United States Innovation Centers

J Med Internet Res 2020;22(9):e19644

DOI: 10.2196/19644

PMID: 32975524

PMCID: 7547390

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Accelerating innovation in healthcare – insights from a qualitative enquiry into U.K. and U.S. innovation centres

  • Kathrin Cresswell; 
  • Robin Williams; 
  • Narath Carlisle; 
  • Aziz Skeikh

ABSTRACT

Background:

Digital health innovations are high on international policy agendas, in the hope that they will help to address existing health system challenges.

Objective:

To explore the set-up, design, facilities, and strategic priorities of leading U.K. and U.S. healthcare innovation centres in order to identify transferable lessons for accelerating the creation and maximising the impact of these.

Methods:

We conducted qualitative case studies consisting of semi-structured audio-recorded interviews with decision makers and centre staff in six innovation centres. We also conducted non-participant observations of meetings and centre tours, where we took field notes. Qualitative data were analysed initially within and then across cases facilitated by NVivo software.

Results:

Centres had different institutional arrangements including university-associated institutes/innovation labs, business accelerators/incubators, and academic health science partnership models. We conducted interviews with 34 individuals, one group interview with three participants, and observed four meetings. Although centres differed significantly in relation to mission and structure/governance, we observed key common characteristics. These included high-level leadership support and incentives to engage in innovation activities, a clear mission to address identified gaps within their respective organisational and health system settings, physical spaces that facilitated networking through open-door policies, flat managerial structures characterised by new organisational roles for which boundary spanning was key, and a wider innovation ecosystem that was strategically and proactively engaged with the centre facilitating external partnerships.

Conclusions:

Although innovation in healthcare settings is unpredictable, we offer insights that may help those establishing innovation centres in healthcare settings. Key in this respect is the ability to support different kinds of innovations at different stages through adequate support structures, including the development of new career pathways.


 Citation

Please cite as:

Cresswell K, Williams R, Carlisle N, Skeikh A

Accelerating Innovation in Health Care: Insights From a Qualitative Inquiry Into United Kingdom and United States Innovation Centers

J Med Internet Res 2020;22(9):e19644

DOI: 10.2196/19644

PMID: 32975524

PMCID: 7547390

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.